Salk Institute welcomes venture capitalist and inventor Andrew Senyei to Board of Trustees
Physician, inventor, and venture capitalist Andrew “Drew” Senyei, MD, has been newly appointed to the Salk Institute’s Board of Trustees.
Press Releases
Explore a featured selection of my work on research and clinical news releases.
Eight Salk scientists named among the most Highly Cited Researchers in the world
Salk faculty members Joseph Ecker, Ronald Evans, Rusty Gage, Christian Metallo, Satchin Panda, Reuben Shaw, and Kay Tye have all been named in this year’s Highly Cited Researchers list by Clarivate.
Salk scientist Deepshika Ramanan receives NIAID New Innovators Award
The five-year, $1.5 million grant will support Ramanan’s pioneering research on maternal immunity during pregnancy and lactation.
From injury to agony: Scientists discover brain pathway that turns pain into suffering
Salk scientists uncover a key neural circuit in mice that gives pain its emotional punch, opening new doors for treating fibromyalgia, migraine, and PTSD
Salk Institute promotes three faculty members in neuroscience, immunology, and cancer research
Three Salk Institute faculty members have been promoted for their notable, innovative contributions to science. Associate Professors Nicola Allen and Diana Hargreaves were promoted to full professors, and Assistant Professor Jesse Dixon was promoted to associate professor.
Through the looking glass: A cross-chiral reaction challenges our definition of life
Salk scientists achieve cross-chiral exponential amplification, potentially enabling a new form of artificial life and innovative drug development strategies
New brain-mapping tool may be the “START” of next-generation therapeutics
Salk scientists debut a method for identifying connectivity between brain cell types with unprecedented resolution.
One in three Americans has a dysfunctional metabolism, but intermittent fasting could help
A clinical trial from the Salk Institute and UC San Diego School of Medicine showed time-restricted eating improved cardiometabolic health in adults with metabolic syndrome.
Salk awarded $3.6 million by CIRM
The funding will help Salk scientists, led by Professor Rusty Gage, share their stem cell technologies with other institutions across the state.
Salk Professor Janelle Ayres named Howard Hughes Medical Institute Investigator
Salk Professor Janelle Ayres has been selected as a 2024 Howard Hughes Medical Institute (HHMI) Investigator.
Salk scientist Jesse Dixon named 2024 Pew Biomedical Scholar
Salk Institute Assistant Professor Jesse Dixon has been named a 2024 Pew Biomedical Scholar by The Pew Charitable Trusts.
Unveiling Telo-seq: A breakthrough in telomere research on aging and cancer
Salk scientists debut a method for determining the length and sequence of telomeres on individual chromosomes, revealing new insights into their dynamics in health and disease
Salk Professor Satchin Panda named 2023 AAAS Fellow
Salk Institute Professor Satchidananda Panda has been named a 2023 AAAS Fellow for his contributions to the field of chronobiology.
A step towards clinic-ready patient-derived organoids
Salk scientists test whether different commercial cell culture products affect organoid development and response to pancreatic cancer drugs
Modeling the origins of life: New evidence for an “RNA World”
Salk scientists unveil RNA capabilities that enable Darwinian evolution at a molecular scale, and bring researchers closer to producing autonomous RNA life in the laboratory
Salk scientists discover new target for reversible, non-hormonal male birth control
Oral administration of HDAC inhibitor blocked sperm production and fertility in mice without affecting libido
UC San Diego Human Milk Institute Names its Executive Director
Mitra Hooshmand, PhD, will lead strategy and operations at the innovative research institute
Stem Cell Therapy Rescues Symptoms of Alzheimer’s Disease
In the ongoing search for a cure for Alzheimer’s disease, a burgeoning branch of medicine is bringing new hope. Stem cell therapies are already being used to treat various cancers and disorders of the blood and immune system. In a new proof-of-concept study, scientists at University of California San Diego show stem cell transplants may also be a promising therapeutic against Alzheimer’s. In the study, published August 8, 2023 in Cell Reports, the researchers demonstrate that transplanting hemat
Can Field Sobriety Tests Identify Drivers Under the Influence of Cannabis?
UC San Diego scientists evaluate how accurate law-enforcement administered field sobriety tests are at measuring cannabis exposure and impairment
Asymptomatic infections may underlie recent rise in whooping cough
In a new study published in Cell Host & Microbe, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions of the whooping cough vaccine. The unexpected findings may help explain the recent rise in whooping cough cases and point to potential targets for the next generation of vaccines.
New Resource Harmonizes 16S and Shotgun Sequencing Data for Microbiome Research
UC San Diego scientists debut Greengenes2, a massive reference database that could be used to reconcile years of microbiome studies
Gulf War Illness Caused by Mitochondrial Dysfunction, Not Inflammation
UC San Diego scientists contest longstanding hypothesis about mysterious illness affecting Gulf War veterans, providing first direct evidence that symptoms are driven by impaired mitochondria
One-Two Punch: Novel Drug Pairing Could Beat Pancreatic Cancer
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
Tethering of Shattered Chromosomal Fragments Paves Way for New Cancer Therapies
UC San Diego scientists discover shattered chromosomal fragments are tethered together during cell division before being rearranged; destroying the tether may help prevent cancerous mutations
Load More
